• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FIDIA FARMACEUTICI SPA HYALGAN PFS 20MG/2ML; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FIDIA FARMACEUTICI SPA HYALGAN PFS 20MG/2ML; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
Reported to (b)(6) by: patient/caregiver.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYALGAN PFS 20MG/2ML
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FIDIA FARMACEUTICI SPA
MDR Report Key15462529
MDR Text Key300466936
Report NumberMW5112187
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient SexFemale
-
-